2014
DOI: 10.1590/s1415-47572014000200018
|View full text |Cite
|
Sign up to set email alerts
|

A tribute to José María ("Chema") Cantú

Abstract: José María (“Chema”) Cantú (1938–2007), born in Mexico, was a pioneering, loved and respected leader in medical and human genetics and bioethics in Latin America. He graduated as a physician in Mexico and then trained in medical and human genetics in France and the United States. He was instrumental in developing a first-rate research, training and genetic services program in medical and human genetics in Guadalajara, in northwestern Mexico. He acted forcefully at national, regional and international levels to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 10 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…LatAm has contributed with world-renowned medical geneticists throughout time. These include the Brazilians Antonio Richieri-Costa and Maria Leine Guion-Almeida, who described new syndromes and delineated many others ( Richieri-Costa and Guion-Almeida, 1992 ; Guion-Almeida et al , 2006 ; Gil‐da‐Silva‐Lopes, 2019 ); the Argentinian Eduardo E. Castilla, who started the Latin American Collaborative Study of Congenital Malformations (ECLAMC), a pioneering, observational, prospective study on congenital malformations across the continent ( Cavalcanti, 2018 ); the Mexican José María Cantú, who delineated several syndromes associated with camptodactyly and the syndrome with his name ( Penchaszadeh et al, 2014 ); and Luis Morquio, who delineated Mucopolysaccharidosis Type IVa for first time almost a hundred years ago ( Baujat and Valayannopoulos, 2014 ). More recently, the contribution of thousands of Venezuelans allowed mapping and subsequent discovery of the HTT gene, responsible of Huntington’s disease, where the contribution of Venezuelan geneticist Ernesto Bonilla was crucial ( Gusella et al, 1983 ; The Huntington’s Disease Collaborative Research Group, 1993 ).…”
Section: Introductionmentioning
confidence: 99%
“…LatAm has contributed with world-renowned medical geneticists throughout time. These include the Brazilians Antonio Richieri-Costa and Maria Leine Guion-Almeida, who described new syndromes and delineated many others ( Richieri-Costa and Guion-Almeida, 1992 ; Guion-Almeida et al , 2006 ; Gil‐da‐Silva‐Lopes, 2019 ); the Argentinian Eduardo E. Castilla, who started the Latin American Collaborative Study of Congenital Malformations (ECLAMC), a pioneering, observational, prospective study on congenital malformations across the continent ( Cavalcanti, 2018 ); the Mexican José María Cantú, who delineated several syndromes associated with camptodactyly and the syndrome with his name ( Penchaszadeh et al, 2014 ); and Luis Morquio, who delineated Mucopolysaccharidosis Type IVa for first time almost a hundred years ago ( Baujat and Valayannopoulos, 2014 ). More recently, the contribution of thousands of Venezuelans allowed mapping and subsequent discovery of the HTT gene, responsible of Huntington’s disease, where the contribution of Venezuelan geneticist Ernesto Bonilla was crucial ( Gusella et al, 1983 ; The Huntington’s Disease Collaborative Research Group, 1993 ).…”
Section: Introductionmentioning
confidence: 99%
“…The first symposium, 'Pharmacogenetics of indigenous and mestizo populations and its clinical implications' was chaired by Ronald Ramírez Roa (UNAN-Leon, Nicaragua). The first talk was given by Enrique Teran (USFQ, Ecuador) who presented a historical overview of the Ibero-American Program for Science, Technology and Development (CYTED), and how the late Mexican geneticist Jose María 'Chema' Cantú and a Spanish clinical pharmacologist, Adrián LLerena were the keystone for the Iberoamerican Network on Pharmacogenetics [6].…”
mentioning
confidence: 99%